Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access
pharmaphorum
JANUARY 21, 2022
It has become clear that the medicines of the 20 th century, the so-called blockbuster era, are gradually being replaced by drugs designed for smaller groups, specific indication, and even for individual patients,” said Jo De C**k, CEO of Belgium’s National Institute for Health and Disability Insurance. Finding solutions.
52 
Let's personalize your content